![]() Nanjing King-Friend Biochemical Pharmaceutical Nanjing King-Friend Biochemical Pharmaceutical (NKF, 南京健友生化制药股份有限公司) is a company that specializes in the research, production, and sales of medicines and health products. | ![]() UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | ![]() Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. | |
Founding Date | Founding Date 2000 | Founding Date 1928 | Founding Date 1976 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Nanjing, CN HQ Chengdu, CN Cork, IE Milano, IT Altrincham, GB Chicago, US | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more |
Employees | Employees 1,3606% decrease | Employees 9,052 | Employees 18,077 |
Valuation ($) | Valuation ($) 3.3 b | Valuation ($) 34.3 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) ¥4b (FY, 2025) | Revenue (est.) €7.4b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥2.4b (FY, 2025) | Cost of goods €1.4b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit ¥1.5b (FY, 2025) | Gross profit €7.2b (FY, 2025) | Gross profit N/A |
Net income | Net income ¥581.5m (FY, 2025) | Net income €1.6b (FY, 2025) | Net income N/A |

UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
View company